CSIMarket
 


Longeveron Inc   (LGVN)
Other Ticker:  
 

Cumulative Longeveron Inc 's Total Debt to Equity for Trailing Twelve Months Period

LGVN's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

LGVN Total Debt to Equity for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Growth 10.22 % 19.19 % - - -
Y / Y Total Debt Growth -9.59 % -9.33 % - - -
Total Debt to Equity for Trailing Twelve Months Period 0.09 0.09 0.1 0.1 0.13
Total Ranking # 564 # 542 # 372 # 21 #
Seq. Equity Growth -16.22 % -14.36 % -8.4 % 67.7 % -9.4 %
Seq. Total Debt Growth -4.66 % -4.45 % 15.55 % -14.11 % -4.38 %


Total Debt to Equity for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to repayements of liabilities of -4.66% Longeveron Inc has not changed Total Debt to Equity for Trailing Twelve Months Period in the III. Quarter to 0.09, above Longeveron Inc 's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 40 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Longeveron Inc . While Total Debt to Equity for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from 542 to 564.

What is Debt to Equity Ratio?
LGVN Charts and Quotes
Total Debt to Equity LGVN in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 41
Sector # 128
S&P 500 # 563


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.01 0.01 0
(Sep 30 2022)   (Dec 31 2021)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Total Debt to Equity for Trailing Twelve Months Period
Biomarin Pharmaceutical Inc  0.25 
Aptinyx Inc   0.24 
Evotec Se  0.24 
Neptune Wellness Solutions Inc.  0.22 
Ibio inc   0.22 
Abvc Biopharma Inc   0.22 
Accustem Sciences Inc   0.22 
Elite Pharmaceuticals Inc.  0.20 
Iterum Therapeutics Plc  0.20 
Eagle Pharmaceuticals inc   0.20 
Aytu Biopharma inc   0.20 
Equillium Inc   0.19 
United Therapeutics Corporation  0.19 
Savara Inc   0.19 
Hillstream Biopharma Inc   0.19 
Calliditas Therapeutics Ab  0.19 
Madrigal Pharmaceuticals Inc   0.19 
Uniqure N v   0.18 
Intercure Ltd   0.18 
Liquidia Corporation  0.18 
Verastem Inc   0.17 
Nabriva Therapeutics Plc  0.17 
Mereo Biopharma Group Plc  0.16 
Amphastar Pharmaceuticals Inc   0.16 
Mersana Therapeutics inc   0.16 
Roivant Sciences Ltd   0.16 
Prophase Labs Inc   0.15 
Cerevel Therapeutics Holdings Inc   0.15 
9 Meters Biopharma Inc   0.15 
Spectrum Pharmaceuticals Inc   0.15 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CLOW's Profile

Stock Price

CLOW's Financials

Business Description

Fundamentals

Charts & Quotes

CLOW's News

Suppliers

CLOW's Competitors

Customers & Markets

Economic Indicators

CLOW's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071